Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study.
Lung Cancer
; 172: 154-159, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36099710
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Guideline
Limits:
Humans
Language:
En
Year:
2022
Type:
Article